Prognostic Significance of Small-Artery Structure in Hypertension

Background—The presence of structural alterations in the microcirculation may be considered an important mechanism of organ damage; however, it is not currently known whether structural alterations of small arteries may predict fatal and nonfatal cardiovascular events. Methods and Results—One hundred twenty-eight patients were included in the present study. There were 59 patients with essential hypertension, 17 with pheochromocytoma, 20 with primary aldosteronism, 12 with renovascular hypertension, and 20 normotensive patients with non-insulin-dependent diabetes mellitus. All subjects were submitted to a biopsy of subcutaneous fat. Small resistance arteries were dissected and mounted on an isometric myograph, and the tunica media-to-internal lumen ratio (M/L) was measured. The subjects were reevaluated after an average follow-up time of 5.4 years. Thirty-seven subjects had a documented fatal or nonfatal cardiovascular event (5.32 events/100 patients per year). In the subcutaneous small arteries of subjects with cardiovascular events, a smaller internal diameter and a clearly greater M/L was observed. Our subjects were subdivided according to the presence of an M/L greater or smaller than the mean and median values observed in the whole population (0.098) or mean value +2 SD of our normal subjects (0.11). Life-table analyses showed a significant difference in event-free survival between the subgroups. Cox’s proportional hazard model, considering all known cardiovascular risk factors, indicated that only pulse pressure (P =0.009) and M/L (P <0.0001) were significantly associated with the occurrence of cardiovascular events. Conclusions—Our results strongly indicate a relevant prognostic role of structural alterations in small resistance arteries of a high-risk population.

[1]  E. Porteri,et al.  Relationships between coronary flow vasodilator capacity and small artery remodelling in hypertensive patients. , 2003, Journal of hypertension.

[2]  P. Raskin,et al.  Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.

[3]  E. Porteri,et al.  Structural changes in small resistance arteries and left ventricular geometry in patients with primary and secondary hypertension , 2002, Journal of hypertension.

[4]  A. Heagerty,et al.  The amplifier hypothesis: persisting dissent. , 2002, Journal of hypertension.

[5]  A. Pries,et al.  Microcirculation in Hypertension: A New Target for Treatment? , 2001, Circulation.

[6]  E. Schiffrin,et al.  Small artery remodeling is the most prevalent (earliest?) form of target organ damage in mild essential hypertension , 2001, Journal of hypertension.

[7]  E. Porteri,et al.  Structural Alterations in Subcutaneous Small Arteries of Normotensive and Hypertensive Patients With Non–Insulin-Dependent Diabetes Mellitus , 2001, Circulation.

[8]  E. Schiffrin,et al.  Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan. , 2000, Circulation.

[9]  M Ishii,et al.  [The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, and 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension]. , 2000, Nihon rinsho. Japanese journal of clinical medicine.

[10]  F. Leenen,et al.  The amplifier hypothesis: permission to dissent? , 1999, Journal of hypertension.

[11]  A. Pries,et al.  Structural autoregulation of terminal vascular beds: vascular adaptation and development of hypertension. , 1999, Hypertension.

[12]  A. Dominiczak,et al.  Cellular aspects of vascular remodeling in hypertension revealed by confocal microscopy. , 1997, Hypertension.

[13]  M. Fantone,et al.  Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus , 1997, Diabetes Care.

[14]  B R Masters,et al.  Multiphoton excitation fluorescence microscopy and spectroscopy of in vivo human skin. , 1997, Biophysical journal.

[15]  R. Zulli,et al.  Effects of long‐term antihypertensive treatment with lisinopril on resistance arteries in hypertensive patients with left ventricular hypertrophy , 1997, Journal of hypertension.

[16]  E. Porteri,et al.  Vascular hypertrophy and remodeling in secondary hypertension. , 1996, Hypertension.

[17]  E. Schiffrin,et al.  Structure and function of resistance arteries of hypertensive patients treated with a p-blocker or a calcium channel antagonist , 1996, Journal of hypertension.

[18]  R. Zulli,et al.  Cardiac and vascular structural changes. Prevalence and relation to ambulatory blood pressure in a middle-aged general population in northern Italy: the Vobarno Study. , 1996, Hypertension.

[19]  P. Hamet,et al.  Shanghai trial of nifedipine in the elderly (STONE). , 1996, Journal of hypertension.

[20]  M. Mulvany Resistance vessel growth and remodelling: cause or consequence in cardiovascular disease. , 1995, Journal of human hypertension.

[21]  R. Zulli,et al.  Media: lumen ratio in human small resistance arteries is related to forearm minimal vascular resistance , 1995, Journal of hypertension.

[22]  R. T. Lee,et al.  Integrin-mediated collagen matrix reorganization by cultured human vascular smooth muscle cells. , 1995, Circulation research.

[23]  P. Delaney,et al.  Confocal microscopy in pharmacological research. , 1994, Trends in pharmacological sciences.

[24]  E. Schiffrin,et al.  Effects of a beta-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension. , 1994, Hypertension.

[25]  G A Briggs,et al.  Quantitative acoustic microscopy of individual living human cells , 1993, Journal of microscopy.

[26]  L. Wilkins Proceedings of the Ninth Scientific Meeting of the Inter-American Society of Hypertension. Rio de Janeiro, Brazil, March 10-13, 1991. , 1992, Hypertension.

[27]  P. Korner,et al.  Significance of cardiovascular hypertrophy in the development and maintenance of hypertension. , 1991, Journal of Cardiovascular Pharmacology.

[28]  M. Mulvany,et al.  Structure and function of small arteries. , 1990, Physiological reviews.

[29]  M. Mulvany,et al.  Abnormal structure and function of isolated subcutaneous resistance vessels from essential hypertensive patients despite antihypertensive treatment. , 1989, Journal of hypertension.

[30]  A. Heagerty,et al.  Evidence for increased media thickness, increased neuronal amine uptake, and depressed excitation--contraction coupling in isolated resistance vessels from essential hypertensives. , 1987, Circulation research.

[31]  A. Lever Slow pressor mechanisms in hypertension: a role for hypertrophy of resistance vessels? , 1986, Journal of hypertension.

[32]  H. Bohlen Localization of vascular resistance changes during hypertension. , 1986, Hypertension.

[33]  H. Granger,et al.  Power dissipation as a measure of peripheral resistance in vascular networks. , 1986, Hypertension.

[34]  T. Neild,et al.  Images of arterioles in unfixed tissue obtained by acoustic microscopy , 1985, Journal of microscopy.

[35]  B. Folkow Physiological aspects of primary hypertension. , 1982, Physiological reviews.

[36]  M. Mulvany,et al.  Direct Evidence that the Greater Contractility of Resistance Vessels in Spontaneously Hypertensive Rats is Associated with a Narrowed Lumen, a Thickened Media, and an Increased Number of Smooth Muscle Cell Layers , 1978, Circulation research.

[37]  A. DeMaria,et al.  Recommendations Regarding Quantitation in M-Mode Echocardiography: Results of a Survey of Echocardiographic Measurements , 1978, Circulation.

[38]  M. Mulvany,et al.  Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. , 1977, Circulation research.